Tumor-associated antigens: from discovery to immunity (Q35214398)

7 August 2017

1 reference

title

Tumor-associated antigens: from discovery to immunity (English)

1 reference

7 August 2017

Jennifer D Lewis

1

1 reference

7 August 2017

Brian D Reilly

series ordinal

2

1 reference

7 August 2017

Robert K Bright

series ordinal

3

1 reference

7 August 2017

publication date

1 March 2003

1 reference

International Reviews of Immunology

7 August 2017

published in

1 reference

7 August 2017

volume

22

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

81-112

1 reference

Ligand recognition by alpha beta T cell receptors

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

FIV infection of the domestic cat: an animal model for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Viral immunopathology of human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Recombinant Toxins for Cancer Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

HTLV x-gene product: requirement for the env methionine initiation codon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Cellular peptide composition governed by major histocompatibility complex class I molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Kaposi's sarcoma-associated virus mounts novel attack on immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Hepatitis B virus and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

New use of BCG for recombinant vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Molecular alterations in pediatric sarcomas: potential targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Peptide binding to MHC class I molecules: implications for antigenic peptide prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Antigens recognized by autologous antibody in patients with renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Immunotherapeutic potential of whole tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Genetic vaccines--a revolution in vaccinology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

The next wave of recombinant and synthetic anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Heat shock protein-peptide complexes in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

The role of complement in inflammation and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

De-novo mutation and sporadic presentation of acute intermittent porphyria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Danger versus tolerance: paradigms for future studies of tumor-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-1984. Pulmonary infiltrates 12 years after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Characterization of human colon cancer antigens recognized by autologous antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

The radius of gyration of an apomyoglobin folding intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

Approaches to the identification and molecular cloning of chromosome breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180305221

21 January 2018

Identifiers

DOI

10.1080/08830180305221

1 reference

7 August 2017

1 reference